Indaptus Therapeutics
INDP
5 hedge funds and large institutions have $57.9K invested in Indaptus Therapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
1,692% more capital invested
Capital invested by funds: $3.23K → $57.9K (+$54.7K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
1.81% more ownership
Funds ownership: 0% → 1.81% (+1.8%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$137K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.62K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.63K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SS
SBI Securities
Tokyo,
Japan
|
-$1K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$105 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$21 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $55K | +$137K | +18,997 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1.44K | +$3.62K | +502 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1.36K | +$2.63K | +365 | +338% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $94 | +$14 | +2 | +6% |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $49 | -$1K | -139 | -89% |
|
|
6
Fidelity Investments
Boston,
Massachusetts
| – | -$105 | -10 | Closed |
|
|
7
Wells Fargo
San Francisco,
California
| – | -$21 | -2 | Closed |
|
INDP Hedge Fund Activity: Q3 2025 in Review
5 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q3 2025, worth a combined $57.9K — up 1,692% from $3.23K a quarter earlier.
Fund positioning in INDP was balanced in Q3 2025: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $137K. The largest seller was SBI Securities, cutting an estimated $1K.
- 5 institutional investors held Indaptus Therapeutics (INDP) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $57.9K of Indaptus Therapeutics stock for Q3 2025, up 1,692% quarter-over-quarter.
- 2 funds opened new Indaptus Therapeutics positions in Q3 2025 and 2 closed out, a net change of 0 holders.
- The largest Indaptus Therapeutics buyer in Q3 2025 was Virtu Financial, an estimated $137K added.
- The largest Indaptus Therapeutics seller in Q3 2025 was SBI Securities, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2025.